PI3Kδ inhibitor idelalisib in combination with BTK inhibitor ONO/GS-4059 in diffuse large B cell lymphoma with acquired resistance to PI3Kδ and BTK inhibitors

Anella Yahiaoui, Stacey Tannheimer|PLoS ONE|2017

Cited by 51